Cambridge Investment Research Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 7,765 shares of IONS stock, worth $234,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,765
Previous 9,738
20.26%
Holding current value
$234,270
Previous $390,000
30.51%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$497 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$427 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$346 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$311 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$237 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...